Ergoteles’s Oncorus, Inc. ONCR Stock Holding History

Ergoteles’s Portfolio ONCR Stock Details ONCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,707	Closed	-$3.73K	–	1954
2022 Q4	$3.73K	Sell	14,707 -71,428	-83%	-$40.6K	﹤0.01%	1390
2022 Q3	$73K	Sell	86,135 -12,465	-13%	-$16K	﹤0.01%	1412
2022 Q2	$124K	Buy	+98,600	New	+$134K	﹤0.01%	1461

Other funds holding ONCR

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ergoteles's ONCR Position: Q1 2023 in Review

Ergoteles sold out of Oncorus, Inc. (ONCR) in Q1 2023, closing a stake of 14,707 shares — an estimated $3.73K sold.

Ergoteles first reported a position in ONCR in Q2 2022 and held it in 3 quarters. The position peaked at $124K in Q2 2022. 32 funds tracked by Wall St. Rank hold ONCR as of Q1 2023.

Ergoteles reported no remaining Oncorus, Inc. position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 14,707 Oncorus, Inc. shares in Q1 2023, an estimated $3.73K.
Ergoteles first reported a position in Oncorus, Inc. in Q2 2022 and held it in 3 quarters.
Ergoteles's Oncorus, Inc. position peaked at $124K in Q2 2022.
32 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.